肌肉生長(zhǎng)抑制素(MSTN)檢測(cè)試劑盒(化學(xué)發(fā)光免疫分析法)
CLIA Kit for Myostatin (MSTN)
GDF8; Growth Differentiation Factor 8
- 編號(hào)USCB653Ga
 - 物種Chicken (Gallus,雞) 相同的名稱,不同的物種。
 - 實(shí)驗(yàn)方法雙抗夾心
 - 反應(yīng)時(shí)長(zhǎng)2h, 40min
 - 檢測(cè)范圍27.4-20,000pg/mL
 - 靈敏度最小可檢測(cè)劑量小于等于11.3pg/mL.
 - 樣本類型Serum, plasma and other biological fluids
 - 下載 英文說(shuō)明書 中文說(shuō)明書
 - 規(guī)格 48T96T 96T*5 96T*10 96T*100
 - 價(jià)格 ¥ 1915 ¥ 2736 ¥ 12312 ¥ 23256 ¥ 191520
 - 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
 
特異性
                        本試劑盒用于檢測(cè)肌肉生長(zhǎng)抑制素(MSTN),經(jīng)檢測(cè)與其它相似物質(zhì)無(wú)明顯交叉反應(yīng)。
                        由于受到技術(shù)及樣本來(lái)源的限制,不可能完成對(duì)所有相關(guān)或相似物質(zhì)交叉反應(yīng)檢測(cè),因此本試劑盒有可能與未經(jīng)檢測(cè)的其它物質(zhì)有交叉反應(yīng)。
                    
回收率
分別于定值血清及血漿樣本中加入一定量的肌肉生長(zhǎng)抑制素(MSTN)(加標(biāo)樣品),重復(fù)測(cè)定并計(jì)算其均值,回收率為測(cè)定值與理論值的比率。
| 樣本 | 回收率范圍(%) | 平均回收率(%) | 
| serum(n=5) | 83-105 | 101 | 
| EDTA plasma(n=5) | 86-94 | 90 | 
| heparin plasma(n=5) | 95-102 | 98 | 
精密度
                    精密度用樣品測(cè)定值的變異系數(shù)CV表示。CV(%) = SD/mean×100 
                    批內(nèi)差:取同批次試劑盒對(duì)低、中、高值定值樣本進(jìn)行定量檢測(cè),每份樣本連續(xù)測(cè)定20 次,分別計(jì)算不同濃度樣本的平均值及SD值。
                    批間差:選取3個(gè)不同批次的試劑盒分別對(duì)低、中、高值定值樣本進(jìn)行定量測(cè)定,每個(gè)樣本使用同一試劑盒重復(fù)測(cè)定8次,分別計(jì)算不同濃度樣本的平均值及SD值。
                    批內(nèi)差: CV<10% 
                    批間差: CV<12% 
                
線性
在定值血清及血漿樣本內(nèi)加入適量的肌肉生長(zhǎng)抑制素(MSTN),并倍比稀釋成1:2,1:4,1:8,1:16的待測(cè)樣本,線性范圍即為稀釋后樣本中肌肉生長(zhǎng)抑制素(MSTN)含量的測(cè)定值與理論值的比率。
| 樣本 | 1:2 | 1:4 | 1:8 | 1:16 | 
| serum(n=5) | 82-89% | 87-105% | 79-97% | 94-105% | 
| EDTA plasma(n=5) | 88-101% | 83-96% | 85-92% | 94-103% | 
| heparin plasma(n=5) | 81-99% | 92-101% | 88-95% | 82-97% | 
穩(wěn)定性
                    經(jīng)測(cè)定,試劑盒在有效期內(nèi)按推薦溫度保存,其活性降低率小于5%。
                    為減小外部因素對(duì)試劑盒破壞前后檢測(cè)值的影響,實(shí)驗(yàn)室的環(huán)境條件需盡量保持一致,尤其是實(shí)驗(yàn)室內(nèi)溫度、濕度及溫育條件。其次由同一實(shí)驗(yàn)員來(lái)進(jìn)行操作可減少人為誤差。
                
實(shí)驗(yàn)流程
                    1. 實(shí)驗(yàn)前標(biāo)準(zhǔn)品、試劑及樣本的準(zhǔn)備;
                            2. 加樣(標(biāo)準(zhǔn)品及樣本)100µL,37°C孵育1小時(shí);
                            3. 吸棄,加檢測(cè)溶液A100μL,37°C孵育1小時(shí);
                            4. 洗板3次;
                            5. 加檢測(cè)溶液B100µL,37°C孵育30分鐘;
                            6. 洗板5次;
                            7. 加底物100µL,37°C孵育10分鐘;
                            8. 讀數(shù)。
                
實(shí)驗(yàn)原理
將肌肉生長(zhǎng)抑制素(MSTN)抗體包被于96孔微孔板中,制成固相載體,向微孔中分別加入標(biāo)準(zhǔn)品或標(biāo)本,其中的肌肉生長(zhǎng)抑制素(MSTN)與連接于固相載體上的抗體結(jié)合,然后加入生物素化的肌肉生長(zhǎng)抑制素(MSTN)抗體,將未結(jié)合的生物素化抗體洗凈后,加入HRP標(biāo)記的親和素,再次徹底洗滌后加入底物。加入底物后會(huì)產(chǎn)生輝光型光信號(hào)。發(fā)射光強(qiáng)度和樣品中的肌肉生長(zhǎng)抑制素(MSTN)呈正相關(guān)。用化學(xué)發(fā)光儀測(cè)定相對(duì)光單位(RLU),計(jì)算樣品濃度。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種:Chicken (Gallus,雞) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) | 
| URPB653Ga01 | 肌肉生長(zhǎng)抑制素(MSTN)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| UCPB653Ga21 | 肌肉生長(zhǎng)抑制素(MSTN)卵白蛋白偶聯(lián)物 | Immunogen; SDS-PAGE; WB. | 
| UPAB653Ga08 | 肌肉生長(zhǎng)抑制素(MSTN)多克隆抗體 | WB; IHC; ICC; IP. | 
| UPAB653Ga01 | 肌肉生長(zhǎng)抑制素(MSTN)多克隆抗體 | WB; IHC; ICC; IP. | 
| UMAB653Ga21 | 肌肉生長(zhǎng)抑制素(MSTN)單克隆抗體 | WB; IHC; ICC; IP. | 
| USEB653Ga | 肌肉生長(zhǎng)抑制素(MSTN)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| USCB653Ga | 肌肉生長(zhǎng)抑制素(MSTN)檢測(cè)試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. | 
| ULMB653Ga | 肌肉生長(zhǎng)抑制素(MSTN)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. | 
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) | 
| Clinical Medicine and Diagnostics | Anti-Myostatin Reduces Bone Mineral Loss in Ovariectomized Rats [Sapub:Source] | 
| Nutr Metab (Lond) | Short-term, high-fat diet accelerates disuse atrophy and protein degradation in a muscle-specific manner in mice [PubMed: 26539241] | 
| International Journal of Cancer | Tumor inoculation site affects the development of cancer cachexia and muscle wasting [PubMed: 26016447] | 
| Connect Tissue Res | Induction of transient tenogenic phenotype of high density cultured human dermal fibroblasts [PubMed: 25748814] | 
| PLoS One | Higher Plasma Myostatin Levels in Cor Pulmonale Secondary to Chronic Obstructive Pulmonary Disease [Pubmed:26998756] | 
| Calcif Tissue Int. | The Effect of Vibration Treatments Combined with Teriparatide or Strontium Ranelate on Bone Healing and Muscle in Ovariectomized Rats [Pubmed:27272029] | 
| Archives of medical research | Irisin and Myostatin Levels in Patients with Graves' Disease. [pubmed:27986127] | 
| Calcified Tissue International | Effect of?Strontium Ranelate on?the?Muscle and?Vertebrae of?Ovariectomized Rats [pubmed:29242963] | 
| Scientific Reports | Compensatory anabolic signaling in the sarcopenia of experimental chronic arthritis. [pubmed:28740214] | 
| Journal of?Animal?Science | Fermented corn-soybean meal elevated IGF1 levels in grower-finisher pigs [Pubmed: 30203098] | 
| European Journal of Internal Medicine | Predictive value of serum myostatin for the severity and clinical outcome of heart failure [Pubmed: 31056368] | 
| J Cell Physiol | Resistance training‐induced muscle hypertrophy is mediated by TGF‐β1‐Smad signaling pathway in male Wistar rats [Pubmed: 31960436] | 
| NEPHROLOGY DIALYSIS TRANSPLANTATION | Myostatin and muscle atrophy during chronic kidney disease [Pubmed: 32974666] | 
| Oxid Med Cell Longev | Gender-Specific Behaviour in Obesity Stages I-II: Imbalance of Aminothiol Status and Adipomyokine Profile in Subjects with Different Insulin Resistance?… [34868459] | 

                    
                    
                                    